Statin use vs. average non-HDL cholesterol levels in Papua New Guinea
Papua New Guinea: Statin use vs. average non-HDL cholesterol levels was 3.6 in 2018. ▲ Rising
Statin use vs. average non-HDL cholesterol levels in Papua New Guinea, 1980–2018
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
Papua New Guinea recorded 3.6 for statin use vs. average non-hdl cholesterol levels in 2018. That is the highest value across all 39 years on record.
Compared with earlier readings it is unchanged over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in Papua New Guinea peaked at 3.6 in 2006 and was at its lowest, 3.2, in 1980.
That places Papua New Guinea 30th out of 191 countries with data for 2018, putting it in the top quarter.
The long-run direction has been consistently rising across the 39 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 3.33 | 3.2 | 3.4 | 10 |
| 1990s | 3.48 | 3.4 | 3.5 | 10 |
| 2000s | 3.54 | 3.5 | 3.6 | 10 |
| 2010s | 3.6 | 3.6 | 3.6 | 9 |
Countries ranked near Papua New Guinea
- 30 Albania 3.6 compare
- 30 Andorra 3.6 compare
- 30 Austria 3.6 compare
- 30 Bulgaria 3.6 compare
- 30 Dominican Republic 3.6 compare
- 30 Estonia 3.6 compare
- 30 Hungary 3.6 compare
- 30 Indonesia 3.6 compare
- 30 Jamaica 3.6 compare
- 30 Jordan 3.6 compare
- 30 Montenegro 3.6 compare
- 30 North Macedonia 3.6 compare
- 30 Portugal 3.6 compare
- 30 Romania 3.6 compare
- 30 Russia 3.6 compare
- 30 Slovakia 3.6 compare
- 30 Slovenia 3.6 compare
- 30 Ukraine 3.6 compare
- 30 Uruguay 3.6 compare
- 30 Uzbekistan 3.6 compare
- 30 Vanuatu 3.6 compare
More reference data data for Papua New Guinea
- Temperature anomalies by month 0.504 °C (2026)
- Spring temperature anomalies 0.1159 °C (2026)
- Summer temperature anomalies -0.0178 °C (2026)
- Elected parliament 1 (2025)
- Civil liberties rating 3 (2025)
- Free country 1 (2025)
- Universal right to vote in practice 2 (2025)
- Autumn temperature anomalies 0.6022 °C (2025)
- Men's universal right to vote 1 (2025)
- Winter temperature anomalies 0.257 °C (2025)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in Papua New Guinea?
- Statin use vs. average non-hdl cholesterol levels in Papua New Guinea was 3.6 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in Papua New Guinea?
- The highest recorded value was 3.6 in 2006.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Papua New Guinea?
- The lowest recorded value was 3.2 in 1980.
- How does Papua New Guinea rank for statin use vs. average non-hdl cholesterol levels?
- Papua New Guinea ranks 30th out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in Papua New Guinea?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Papua New Guinea data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.